查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466284

心血管設備市場：按設備類型、適應症和最終用戶分類 - 全球預測 2024-2030

Cardiovascular Devices Market by Device Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Indication (Cardiac Arrhythmia, Coronary Artery Disease, Heart Failure), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年心血管器材市場規模為536.9億美元，預計2024年將達575.5億美元，2030年將達884億美元，複合年成長率為7.38%。

心血管設備是用於診斷、治療和管理與心臟和循環系統相關的疾病的專用設備和工具。這包括廣泛的產品，包括心律調節器、支架、心臟瓣膜、監測設備和手術器械。由於人口老化、久坐的生活方式以及高血壓、糖尿病和普及等危險因子的普遍存在，全球心血管疾病發病率不斷上升，推動了這一趨勢的發展。技術創新和研發進步相結合，顯著提高了這些設備的有效性和安全性，進一步推動了需求。然而，市場面臨嚴格的監管環境、先進心血管設備的高成本以及需要熟練的專業人員操作先進設備等挑戰。另一方面，由於醫療保健成本不斷上升、持續心臟健康監測的穿戴式技術的整合、對心血管疾病的認知不斷提高以及對微創手術的需求不斷成長，新興市場代表著巨大的成長機會。此外，持續研究帶來具有成本效益的創新產品，可能為該領域的擴張開闢新的途徑。

主要市場統計
基準年[2023] 536.9億美元
預測年份 [2024] 575.5億美元
預測年份 [2030] 884億美元
複合年成長率（%） 7.38%

設備類型：對於診斷和管理高血壓至關重要的血壓計的採用正在迅速增加

血壓計測量動脈血壓，對於高血壓的診斷和管理至關重要。心臟 CT 和 MRI 掃描儀是先進的影像工具，可提供心臟結構和功能的詳細影像，有助於檢測心臟病和病症。心電圖 (ECG) 機器記錄一段時間內心臟的電活動，以診斷心律和其他心血管問題。動態心電圖類似於心電圖，是一種攜帶式設備，可以在 24 小時內追蹤心律和電活動，並可以幫助檢測標準心電圖上可能無法顯示的心律不整。遠端心臟監測系統可以使用無線技術遠距離監測患者的心臟活動，對於患有慢性心臟病的患者特別有用。壓力測試系統檢查身體壓力下的心臟功能，通常是在跑步機或固定自行車上進行。您可以發現休息時不易察覺的心臟疾病。人造心臟是一種植入以替代衰竭心臟的裝置，通常是暫時的，直到可以進行心臟移植為止。心肌消融導管用於心肌消融術，透過疤痕或破壞導致心律異常的心臟組織來治療心律異常。冠狀動脈導管導引線是細而柔韌的導線，可用於在打開心臟阻塞動脈的手術過程中引導支架和球囊等裝置的放置。心臟監視器類似心電圖監測，記錄心臟活動，可以長時間使用。它通常用於手術後或診斷長期心臟病。機械和生物心臟瓣膜用於取代患病的心臟瓣膜，在瓣膜性心臟病的治療中發揮重要作用。植入式心臟整流去顫器(ICD) 會監測心律，並在必要時進行電擊，使其恢復正常心律。用於有心臟猝死風險的患者。心律調節器植入胸部以控制異常心律，並使用電脈衝促進心臟正常跳動。支架是插入狹窄或阻塞動脈的小管，以保持動脈暢通並改善流向心臟的血液。輔助人工心臟(VAD) 是一種機械泵，可為心臟衰弱的人提供心臟功能和血流支持。

最終用戶：擴大心血管設備在門診手術中心的使用

門診手術中心是提供手術和某些不需要住院治療的醫療程序的醫療機構。由於其成本效益和效率，ASC 擴大被用作小型心臟相關手術的心血管設備。這些中心擁有用於門診心臟手術的設備，包括診斷測試和小型手術。 ASC 的一個關鍵優勢是能夠提供高品質、及時的患者照護並減少住院需求。醫院配備了各種等級的心臟護理設備，從基本的診斷設備到先進的手術設備。醫院對於急性心臟疾病的管理、危重手術的實施以及提供包括診斷、治療和復健在內的綜合護理至關重要。該醫院廣泛的基礎設施和多學科團隊對於解決複雜的心血管病例至關重要，並在心血管設備市場中發揮關鍵作用。專科診所專注方面醫療保健的特定方面，有些專科診所僅專注於心臟病學和循環系統健康。這些診所主要利用心血管設備進行診斷、持續患者監測和小型治療程序。專科診所以提供有針對性的個人化護理而聞名，並且通常根據心臟病患者的特定需求提供量身定做的服務。我們的重點是慢性心血管疾病管理、預防策略和病患教育，當需要更先進的治療時，我們經常與醫院合作。

區域洞察

在美洲，高額醫療保健支出、先進的醫療保健系統以及主要設備製造商的存在正在推動市場成長。該地區的法規結構非常嚴格，食品藥物管理局(FDA)監督設備核准，以確保安全性和有效性。由於醫療設施的改善、可支配收入的增加以及心血管疾病負擔的增加，亞太地區（APAC）心血管器材市場正在迅速擴張。該地區的特點是監管環境多樣化，各國處於不同的監管發展階段，企業必須謹慎應對。儘管如此，隨著政府增加對醫療基礎設施和保險系統的投資以使醫療保健更容易獲得，中國和印度等快速成長的經濟體為醫療設備製造商提供了巨大的商機。在 EMEA（歐洲、中東和非洲）地區，由於人口老化、醫療保健標準提高以及政府積極努力管理心血管疾病，對心血管設備的需求不斷增加。在該地區營運的公司受益於歐洲國家先進的醫療保健系統以及中東和非洲的新興市場潛力，以及支持市場進入和擴張的不斷發展的法律規範。

FPNV定位矩陣

FPNV定位矩陣對於評估心血管器材市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對心血管設備市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.心血管器材市場規模及預測是多少？

2.在心血管器材市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.心血管器材市場的技術趨勢和法規結構是什麼？

4.心血管器材市場主要廠商的市場佔有率是多少？

5.進入心血管器材市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病負擔增加
      • 人們對微創手術的興趣日益濃厚
      • 改善新興國家的醫療設施並擴大醫療服務範圍
    • 抑制因素
      • 嚴格的監管政策和產品召回
    • 機會
      • 整合穿戴技術持續監測心臟健康
      • 持續研究心血管設備的生物相容性與材料科學
    • 任務
      • 退款政策數量有限
  • 市場區隔分析
    • 設備類型：血壓計的快速普及，對於高血壓的診斷和管理至關重要
    • 最終使用者：門診手術中心心血管設備使用的演變
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章依設備類型分類的心血管設備市場

  • 診斷和監測設備
  • 治療及手術設備

第7章依適應症分類的心血管器材市場

  • 心律不整
  • 冠狀動脈疾病
  • 心臟衰竭
  • 周邊動脈疾病

第8章心血管設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第9章美洲心血管器械市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太心血管器材市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的心血管器材市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • 強生以 131 億美元收購 Shockwave Medical，以加強心血管護理服務
    • Medtronic)和心臟設計實驗室 (Cardiac Design Labs) 在印度推出創新的外部循環記錄器技術
    • InfoBionic 的 MoMe ARC 獲得 FDA核准，堪稱心臟監測領域的一場革命
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-D2073C5D8E6E

[183 Pages Report] The Cardiovascular Devices Market size was estimated at USD 53.69 billion in 2023 and expected to reach USD 57.55 billion in 2024, at a CAGR 7.38% to reach USD 88.40 billion by 2030.

Cardiovascular devices are specialized equipment and tools deployed in diagnosing, treating, and managing diseases related to the heart and the overall cardiovascular system. This range encompasses a broad spectrum of products, including pacemakers, stents, heart valves, monitoring devices, and surgical instruments. The rising incidences of cardiovascular diseases globally, driven by an aging population, sedentary lifestyles, and the prevalence of risk factors including hypertension, diabetes, and obesity, drive the adoption. Innovations in technology, coupled with advancements in research and development, have significantly improved the efficacy and safety of these devices, further propelling their demand. However, the market faces challenges, including stringent regulatory landscapes, high costs associated with advanced cardiovascular devices, and the need for skilled professionals to operate sophisticated equipment. On the other hand, emerging markets represent a significant opportunity for growth, given the increasing healthcare expenditure, wearable technology integration for continuous heart health monitoring, growing awareness about cardiovascular diseases, and the rising demand for minimally invasive procedures. Moreover, continuous research leading to innovative products that offer cost-effective outcomes can open new avenues for expansion in this sector.

KEY MARKET STATISTICS
Base Year [2023] USD 53.69 billion
Estimated Year [2024] USD 57.55 billion
Forecast Year [2030] USD 88.40 billion
CAGR (%) 7.38%

Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension

Blood pressure monitors measure the pressure of blood in the arteries, which is essential for diagnosing and managing hypertension. Cardiac CT & MRI scanners are advanced imaging tools that provide detailed pictures of the heart's structure and function, helping detect heart diseases and conditions. Electrocardiogram devices (ECG devices) record the heart's electrical activity over a period for diagnosing heart rhythms and other cardiovascular problems. Holter monitors are similar to ECGs; these portable devices track the heart's rhythm and electrical activity for 24 hours or more, helping detect irregularities that might not appear during a standard ECG exam. Remote cardiac monitoring systems allow for monitoring a patient's heart activity from a distance using wireless technology, which is especially useful for patients with chronic heart conditions. Stress test systems examine the heart's performance under physical stress, usually on a treadmill or stationary bike. They can detect heart diseases that are not noticeable at rest. Artificial hearts are devices implanted to replace the failing heart, usually used temporarily until a heart transplant can be performed. Cardiac ablation catheters are used in a procedure known as cardiac ablation, and they treat abnormal heart rhythms by scarring or destroying tissue in the heart that triggers abnormal heart rhythm. Coronary guidewires are thin, flexible wires that are useful in guiding the placement of devices such as stents or balloons during procedures to open up blocked arteries in the heart. Heart monitors are similar to Holter monitors; these devices keep track of the heart's activity and can be used for extended periods. They are often used after surgery or to diagnose long-term heart conditions. Heart valves can be mechanical or biological used to replace diseased heart valves and are critical in managing heart valve disorders. Implantable cardioverter defibrillators (ICDs) monitor heart rhythms and deliver electric shocks to restore a normal rhythm if necessary. They're used in patients at risk of sudden cardiac death. Pacemakers are implanted in the chest to control abnormal heart rhythms and use electrical pulses to prompt the heart to beat normally. Stents are tiny tubes inserted into narrow or blocked arteries to keep them open, improving blood flow to the heart. Ventricular assist devices (VADs) are mechanical pumps that support heart function and blood flow in individuals with weakened hearts.

End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers

Ambulatory surgical centers are healthcare facilities that deliver surgery and specific medical procedures that do not require hospital admission. Due to their cost-effectiveness and efficiency, ASCs are increasingly utilized as cardiovascular devices for minor heart-related procedures. These centers have devices for outpatient cardiac procedures, including diagnostic tests and minor surgical interventions. The critical advantage of ASCs is their ability to offer high-quality, timely patient care, reducing the need for hospital stays. Hospitals are equipped with an expansive range of devices, from essential diagnostic tools to advanced surgical equipment, catering to all levels of cardiac care. Hospitals are central to managing acute cardiac conditions, performing significant surgeries, and providing comprehensive care, including diagnosis, treatment, and rehabilitation. The extensive infrastructure and multidisciplinary teams in hospitals are essential for handling complex cardiovascular cases, making them critical players in the cardiovascular device market. Specialty clinics focus on specific aspects of healthcare, with certain clinics dedicated entirely to cardiology and cardiovascular health. These clinics utilize cardiovascular devices primarily for diagnostic purposes, ongoing patient monitoring, and minor treatment procedures. Specialty clinics are known for providing targeted and personalized care, often offering services tailored to the specific needs of patients with heart diseases. They significantly manage chronic cardiovascular conditions, prevention strategies, and patient education, frequently collaborating with hospitals for more advanced care needs.

Regional Insights

In the Americas, the market growth is driven by high healthcare expenditure, sophisticated healthcare systems, and a strong presence of major device manufacturers. The regulatory framework in this region is stringent, with the food and drug administration (FDA) overseeing device approval to ensure safety and efficacy. In the Asia-Pacific (APAC) region, the market for cardiovascular devices is expanding rapidly due to improving healthcare facilities, increasing disposable incomes, and a growing burden of cardiovascular diseases. The region is marked by a diverse regulatory landscape with countries at different stages of regulatory growth, which companies must navigate carefully. Nonetheless, fast-growing economies such as China and India provide significant opportunities for device manufacturers, as governments increasingly invest in health infrastructure and insurance schemes to make healthcare more accessible. The EMEA region showcases a demand for cardiovascular devices driven by an aging population, rising healthcare standards, and favorable government initiatives aimed at cardiovascular disease management. Companies operating in this region benefit from the advanced healthcare systems in European countries and emerging market potential in the Middle East and Africa, guided by the evolving regulatory frameworks to support market entry and expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiovascular Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiovascular Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International Inc., Bexen Medical, Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co., Ltd., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Terumo Medical Corporation, Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Device Type
    • Diagnostic & Monitoring Devices
      • Blood Pressure Monitors
      • Cardiac CT & MRI Scanners
      • Electrocardiogram Devices
      • Holter Monitors
      • Remote Cardiac Monitoring
      • Stress Test Systems
    • Therapeutic & Surgical Devices
      • Artificial Hearts
      • Cardiac Ablation Catheters
      • Coronary Guidewires
      • Heart Monitors
      • Heart Valves
      • Implantable Cardioverter Defibrillators
      • Pacemakers
      • Stents
      • Ventricular Assist Devices
  • Indication
    • Cardiac Arrhythmia
    • Coronary Artery Disease
    • Heart Failure
    • Peripheral Arterial Disease
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cardiovascular Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiovascular Devices Market?

3. What are the technology trends and regulatory frameworks in the Cardiovascular Devices Market?

4. What is the market share of the leading vendors in the Cardiovascular Devices Market?

5. Which modes and strategic moves are suitable for entering the Cardiovascular Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing burden of cardiovascular diseases
      • 5.1.1.2. Rising preference for minimally invasive procedures
      • 5.1.1.3. Improved healthcare facilities and the expanding reach of healthcare services in emerging economies
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory policies and product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of wearable technology for continuous monitoring of heart health
      • 5.1.3.2. Ongoing research in the biocompatibility and material science of cardiovascular device
    • 5.1.4. Challenges
      • 5.1.4.1. Limited number of reimbursement policies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension
    • 5.2.2. End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cardiovascular Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Diagnostic & Monitoring Devices
  • 6.3. Therapeutic & Surgical Devices

7. Cardiovascular Devices Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiac Arrhythmia
  • 7.3. Coronary Artery Disease
  • 7.4. Heart Failure
  • 7.5. Peripheral Arterial Disease

8. Cardiovascular Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Cardiovascular Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiovascular Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Johnson & Johnson Acquires Shockwave Medical for USD 13.1 Billion, Bolstering Its Cardiovascular Care Offerings
    • 12.3.2. Medtronic and Cardiac Design Labs Unveil Revolutionary External Loop Recorder Technology in India
    • 12.3.3. InfoBionic's MoMe ARC Receives FDA Approval for Revolutionizing Cardiac Monitoring
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CARDIOVASCULAR DEVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC CT & MRI SCANNERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC CT & MRI SCANNERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REMOTE CARDIAC MONITORING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REMOTE CARDIAC MONITORING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STRESS TEST SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STRESS TEST SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ARTIFICIAL HEARTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ARTIFICIAL HEARTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ABLATION CATHETERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ABLATION CATHETERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY GUIDEWIRES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY GUIDEWIRES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 195. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 196. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 197. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 206. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 215. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 216. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 217. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 218. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 219. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 226. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 235. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 236. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 237. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 245. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 246. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 247. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 248. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 249. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 255. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 256. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 257. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 273. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 277. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 278. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 279. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 286. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 287. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 288. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 289. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 290. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 291. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 296. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 297. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 298. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 299. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 300. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 301. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 306. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 307. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 308. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 309. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 310. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 311. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGN